Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 9 Similar Profiles
Breast Neoplasms
Medicine & Life Sciences
Somatomedins
Medicine & Life Sciences
Insulin-Like Growth Factor I
Medicine & Life Sciences
IGF Type 1 Receptor
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Somatomedin Receptors
Medicine & Life Sciences
Insulin-Like Growth Factor Binding Proteins
Medicine & Life Sciences
Insulin Receptor
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1998 2029
Insulin Receptor
Breast Neoplasms
Research
APOBEC MUTAGENESIS IN BREAST CANCER
Harris, R., Aihara, H., Harki, D. A., Largaespada, D. A. & Yee, D.
NIH NATIONAL CANCER INSTITUTE (NCI)
8/9/19 → 7/31/24
Project: Research project
Mutagenesis
Breast Neoplasms
Cancer Center Support Grant
Yee, D., AbuSalah, A. M., Basu, S., Beckman, K. B., Bielinsky, A. K., Cooley, S. A., De For, T. E., Falconer, S. N., Felices, M., Griffin, T. J., Hallstrom, T. C., Hatsukami, D. K., Hendrickson, E. A., Hirsch, B. A., Joseph, A. M., Kirstein, M. N., Konety, B. R., Koopmeiners, J., Kuntz, K. M., Lange, C. A., Largaespada, D. A., Le, C. T., LeBeau, A., Lindgren, B. R., Luo, X., Mc Carthy, J. B., McKenna, D. H., Miller, J. S., Moriarity, B. S., Nelson, H. H., O'Sullivan, G., Ondrey, F. G., Pennell, C. A., Petersen, A. J., Peterson, B. A., Peterson, L. A., Sarver, A. L., Shimizu, Y., Siegfried, J. M., Temiz, N. A., Turesky, R., Vogel, R., Wagner, J. E., Wang, J., Weigel, B. J., Weisdorf, D. J., Woo, J. & Yamamoto, M.
NIH NATIONAL CANCER INSTITUTE (NCI)
2/1/19 → 1/31/24
Project: Research project
Neoplasms
A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose ofCapecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive,Locally Advanced or Metastatic Breast Cancer Previously Treated
12/17/18 → 12/31/23
Project: Research project
Hormones
Breast Neoplasms
tesetaxel
Capecitabine
Clinical Trials
Neoplasms
Research Output 1988 2019
Erratum to: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint (npj Breast Cancer, (2018), 4, 1, (26), 10.1038/s41523-018-0074-6)
I-SPY2 Investigators, Dec 1 2019, In : npj Breast Cancer. 5, 1, 2.Research output: Contribution to journal › Comment/debate
Open Access
Axilla
Manuscripts
Clinical Trials
Breast Neoplasms
Jasminum
Green tea catechin extract supplementation does not influence circulating sex hormones and insulin-like growth factor axis proteins in a randomized controlled trial of postmenopausal women at high risk of breast cancer
Samavat, H., Wu, A. H., Ursin, G., Torkelson, C. J., Wang, R., Yu, M. C., Yee, D., Kurzer, M. S. & Yuan, J. M., Apr 1 2019, In : Journal of Nutrition. 149, 4, p. 619-627 9 p.Research output: Contribution to journal › Article
Catechin
Gonadal Steroid Hormones
Somatomedins
Tea
Randomized Controlled Trials
I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer
Wang, H. & Yee, D., Dec 1 2019, In : Current Breast Cancer Reports. 11, 4, p. 303-310 8 p.Research output: Contribution to journal › Review article
Clinical Trials
Breast Neoplasms
Therapeutics
Random Allocation
Pharmaceutical Preparations
5
Citations
(Scopus)
40 years of IGF1: Anti-insulin-like growth factor therapy in breast cancer
Yee, D., Jul 2018, In : Journal of molecular endocrinology. 61, 1, p. T61-T68Research output: Contribution to journal › Review article
Somatomedins
Clinical Trials
Breast Neoplasms
IGF Type 1 Receptor
Estrogen Receptors
6
Citations
(Scopus)
Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment
Ungerleider, N. A., Rao, S. G., Shahbandi, A., Yee, D., Niu, T., Frey, W. D. & Jackson, J. G., Oct 1 2018, In : Breast Cancer Research. 20, 1, 115.Research output: Contribution to journal › Article
Breast Neoplasms
Mutation
Survival
Hormones
Therapeutics